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A 41-year-old man with a partially cystic cardiac mass was referred to our institutions. About 17 years previously, 
he had undergone the excision of a lipoma in the left popliteal 
region. The patient had been well until 3 to 4 months earlier, 
when dyspnea on exertion developed.
Two-dimensional echocardiography (Figure 1A and 1B), 
computed tomography (Figure 2A and 2B), and magnetic 
resonance imaging (Figure 3A and 3B and Movies I--3 in the 
online-only Data Supplement) displayed a patchy lobulated 
epicardial mass (transversal diameter, 7 cm; thickness, 4 cm) 
near the left cardiophrenic angle, partially occupying the left 
ventricular chamber.
Cardiac catheterization showed dislocation of the left ante-
rior descending artery by the mass without a significant coro-
nary stenosis.
A review of his medical history revealed that the tumor 
resected in the popliteal region was actually a myxoid liposar-
coma. Whole-body positron emission tomography revealed only 
a mild myocardial uptake, and a gated myocardial perfusion 
single-photon emission computed tomography (Figure 4 and 
Movies IV and V in the online-only Data Supplement) showed 
a perfusion defect in the myocardial area occupied by the mass. 
Surgical resection of the mass was judged technically feasible, 
so the patient underwent surgery (Figure 5A and 5B).
First, the left phrenic nerve was dissected from the pericar-
dium via an intrapleuric approach, and then dissection of the 
mass was started with an incision of the pericardium around 
the mass. The epicardial fat above the left descending anterior 
coronary artery was dissected, and the mass was separated 
from the epicardial surface of the heart. Extracorporeal cir-
culation was then started. A cleavage plane was found, and 
the mass was resected up to the base of the posterior papil-
lary muscle, which was partially reimplanted. The hole in 
the left ventricular wall was closed by a Dacron patch (2.5 
× 3 cm). The histopathological analysis of the tumor, which 
macroscopically resembled a jellyfish (Figure 5B), revealed 
a low-grade myxoid liposarcoma (Figure 6).
The postoperative course was uneventful, and the patient 
was discharged after 12 days.
The patient presented 8 months later with disease progres-
sion (heart, mediastinum, pleura), so chemotherapy with tra-
bectedin was begun and is still ongoing 1 year after surgical 
treatment.
Liposarcoma is the most common soft-tissue sarcoma; the 
myxoid subtype is the most prevalent and the least aggressive. 
These tumors arise more commonly in the lower extremities 
and have an indolent course, with high disease-free survival 
rates when appropriate surgical resection with or without 
radiotherapy is performed.1 Histological grade remains the 
most important prognostic factor. Myxoid tumors tend to 
metastasize to extrapulmonary and unusual sites, with an over-
all rate of 14.5% at 5 years and 15.3% at 10 years1; the time to 
distant metastases may vary from 3 to 73 months.2 Definitive 
differentiation between metastatic disease and metachronous 
primary disease is often elusive. Primary cardiac sarcoma has 
a worse prognosis compared with secondary tumors, with a 
median overall survival of 6 versus 93 months in a series3; 
median survival is significantly better for patients suitable for 
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Figure 1. Echocardiography. Apical 
4-chamber view showing a large cardiac 
mass infiltrating the apex, lateral, and 
anterior walls of the left ventricle. A second 
small cardiac mass is attached to the left 
wall; presence of pericardial effusion. Con-
trast-enhanced ultrasound shows the large 
infiltrative cardiac mass. Inside the mass 
are large nodular, nonperfused or hypoper-
fused areas surrounded by vascularized 
nonmyocardial tissue infiltrating the normal 
myocardium.
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surgery,3,4 which remains the best therapeutic option, even 
if most patients eventually die of widespread disease. Few 
anecdotal reports have been published on cardiac myxoid 
liposarcomas, so the role of adjuvant therapy (radiotherapy 
or chemotherapy) still needs to be defined. Chemotherapy is 
indicated in extensive disease. Anthracyclines and ifosfamide 
are the agents of choice, but recently the novel agent trabect-
edin has proved to have special antitumor activity in myxoid 
liposarcoma.
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Figure 3. Magnetic resonance imaging 
(2-chamber off-axis view, A and 4-chamber 
off-axis view, B). The mass, expanding 
from the wall to the cavity of the left  
ventricle, is hyperintense on T2–Short Tau 
Inversion Recovery sequences (B) because 
of the myxoid component and presents 
inhomogeneous late enhancement that 
extends to the pericardium on post- 
contrast images (A).
Figure 2. Multislice computed 
tomography axial image of the 
mass projecting inside the left 
ventricle. Volume-rendering tech-
nique reconstruction on a coronal 
plane showing the mass in green 
and the ventricle in red.
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Figure 4. Single-photon emis-
sion computed tomographic 
images (short axis, vertical long 
axis, horizontal long axis) dem-
onstrate a severe transmural (no 
viable myocardium) perfusion 
defect involving the following 
akinetic segments with absent 
systolic thickening: apical ante-
rior, apical septal, and apex, and 
a moderate nontransmural (viable 
myocardium) perfusion defect of 
a medium anterolateral normoki-
netic segment in the distribution 
territory of left descending coro-
nary artery.
Figure 5. Macroscopic view of the mass 
after thoracotomy (A) and at the end of 
surgery (B).
Figure 6. Low-power image of a myxoid liposarcoma that con-
tains a multinodular proliferation of fusiform and round cells 
suspended in a myxoid matrix, creating a lace-like pattern with 
contiguous cartilaginous differentiation (hematoxylin-eosin stain; 
magnification ×50).
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